Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.77 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.77 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.77 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.77 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.65 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.65 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.65 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.65 |
| ▸ | QDPR | P09417 | 2/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Paraquat SCHEMBL21652 | 1.00 | SLC6A4 (0.77) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| Paraquat SCHEMBL4084640 | 0.96 | SLC6A4 (0.72) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| SCHEMBL14596518 | 0.96 | SLC6A4 (0.72) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| Paraquat SCHEMBL11281521 | 0.96 | SLC6A4 (0.72) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| Paraquat SCHEMBL21653 | 0.96 | SLC6A4 (0.72) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| Paraquat SCHEMBL8677067 | 0.96 | SLC6A4 (0.72) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| Paraquat SCHEMBL9650240 | 0.96 | SLC6A4 (0.72) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| Paraquat SCHEMBL8331549 | 0.96 | SLC6A4 (0.72) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| Paraquat SCHEMBL22370108 | 0.96 | SLC6A4 (0.72) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 | |
| Paraquat SCHEMBL599615 | 0.93 | SLC22A2 (0.68) | SLC6A4SLC22A2SLC22A1SLC22A3PABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3906245-B1 | MULTIFUNCTIONAL ORGANOSILICON COMPOUND AND RELATED METHODS, COMPOUNDS, AND COMPOSITIONS | DOW SILICONES CORP (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-3645640-B1 | SILICONE-POLYETHER COPOLYMER, METHOD OF PREPARING SAME, AND SEALANT COMPRISING SAME | DOW SILICONES CORP (US) | 2024-03-06 | — | — | EP | disclosed |
| US-11807775-B2 | Silicone-organic copolymer, sealants comprising same, and related methods | DOW SILICONES CORPORATION (US) | 2023-11-07 | — | — | US | disclosed |
| US-11760841-B2 | Silicone-polycarbonate copolymer, sealants comprising same, and related methods | DOW SILICONES CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
| EP-3898779-B1 | SILICONE-POLYESTER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP (US) | 2023-02-08 | — | — | EP | disclosed |
| EP-3898781-B1 | SILICONE-POLYCARBONATE COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP (US) | 2023-01-04 | — | — | EP | disclosed |
| US-20220064482-A1 | SILICONE-ORGANIC COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORPORATION | 2022-03-03 | — | — | US | disclosed |
| US-20220064383-A1 | SILICONE-POLYACRYLATE COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORPORATION | 2022-03-03 | — | — | US | disclosed |
| EP-3645641-B1 | SILICONE-POLYETHER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP (US) | 2021-08-11 | — | — | EP | disclosed |
| EP-3645639-B1 | SILICONE-POLYETHER COPOLYMER, ISOCYANATE-FUNCTIONAL SILICONE-POLYETHER COPOLYMER FORMED THEREWITH, SILICONE-POLYETHER-URETHANE COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP (US) | 2021-07-21 | — | — | EP | disclosed |
| US-20140182483-A1 | Titanium Containing Hydrosilylation Catalysts And Compositions Containing The Catalysts | DOW CORNING CORPORATION | 2014-07-03 | — | — | US | disclosed |
| US-20140187783-A1 | Hafnium Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts | DOW CORNING CORPORATION | 2014-07-03 | — | — | US | disclosed |
| US-20140183398-A1 | Nickel Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts | DOW SILICONES CORPORATION | 2014-07-03 | — | — | US | disclosed |
| US-20140171547-A1 | Bismuth Containing Complex and Condensation Reaction Curable Compositions and Methods for the Preparation and Use of the Compositions | DOW CORNING CORPORATION | 2014-06-19 | — | — | US | disclosed |
| US-20140135517-A1 | Hydrosilylation Reaction Curable Compositions And Methods For Their Preparation And Use | DOW CORNING CORPORATION (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140100347-A1 | Metal Containing Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts | DOW SILICONES CORPORATION | 2014-04-10 | — | — | US | disclosed |
| US-20140039089-A1 | Compositions Containing Phosphonate Catalysts And Methods For The Preparation And Use Of The Compositions | DOW CORNING CORPORATION (US) | 2014-02-06 | — | — | US | disclosed |
| US-20140018467-A1 | COMPOSITIONS CONTAINING SULFONIC ACID CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2014-01-16 | — | — | US | disclosed |
| US-20080118734-A1 | Coating Compositions | DOW CORNING IRELAND LTD. (IE) | 2008-05-22 | — | — | US | disclosed |
| US-5102446-A | Mixture of cacium chloride and ammonium polyphosphate | AQUALON COMPANY (US) | 1992-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135517-A1 | Hydrosilylation Reaction Curable Compositions And Methods For Their Preparation And Use | HIRA, HIRIP3, CROCC | SLC6A4 4412/4885SLC22A2 4406/4885SLC22A1 4191/4885 |
| US-20140183398-A1 | Nickel Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts | HIRA, ALG8, CAD | SLC6A4 4281/4885SLC22A2 3383/4885SLC22A1 3182/4885 |
| US-20140182483-A1 | Titanium Containing Hydrosilylation Catalysts And Compositions Containing The Catalysts | ITGA1, TMT1A, ITGA2 | SLC6A4 4173/4885SLC22A2 4190/4885SLC22A1 4070/4885 |
| US-20140187783-A1 | Hafnium Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts | HIRA, HACL2, CROCC | SLC6A4 4031/4885SLC22A2 4574/4885SLC22A1 4508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.